Exercises that increase your heart rate — like cycling, climbing stairs, or running — are more effective at reducing blood ...

Although several Group 1 PH (Pulmonary Arterial Hypertension, PAH) medications have been explored in Group 2 PH, to date, no medications have been approved for its treatment. Tectonic is a ...

Addressing sleep-related complaints may enhance symptomatic treatment and management of PAH. Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was ...

"We are excited about the prospects of a novel treatment option for patients who are suffering from pulmonary arterial hypertension," said Dr. John Granton, Director of the Pulmonary Hypertension (PH) ...

Pulmonary arterial hypertension (PAH) is one of five types of pulmonary hypertension. It happens when the blood vessels in your lungs narrow and scar so much that it’s hard for blood to move ...

If you have pulmonary arterial hypertension (PAH), it’s possible to lead an active, productive life. The key is to work closely with a specialist, usually a lung doctor (pulmonologist ...

On March 26th, the US FDA granted approval for Merck’s WINREVAIR™ (sotatercept-csrk), marking a significant milestone in pulmonary arterial hypertension (PAH) treatment. PAH, characterized by ...

Pulmonary hypertension (PH) is a serious condition that occurs when the blood pressure in the pulmonary arteritis is comparatively higher than usual. Pulmonary arteries are a type of blood vessel ...

Merck & Co. said Friday that Canada's Drug Agency recommended the company's Winrevair for reimbursement as a treatment for adults with pulmonary arterial hypertension. The agency recommended the ...

Two Indiana University doctors have been awarded grants by the American Lung Association Research Institute for their ...

ETHealthworld.com brings latest pulmonary arterial hypertension news, views and updates from all top sources for the Indian Health industry.